Development and validation of specific post-transplant risk scores according to the circulatory support status at transplant: A UNOS cohort analysis

被引:6
|
作者
Coutance, Guillaume [1 ,2 ]
Bonnet, Guillaume [2 ]
Kransdorf, Evan P. [3 ]
Loupy, Alexandre [2 ]
Moriguchi, Jaime [3 ]
Leprince, Pascal [1 ]
Kobashigawa, Jon A. [3 ]
Patel, Jignesh K. [3 ]
机构
[1] Sorbonne Univ, La Pitie Salpetriere Hosp, Assistance Publ Hop Paris AP HP, Dept Cardiac Surg,Inst Cardiol,Med Sch, Paris, France
[2] Univ Paris, INSERM UMR 970, Paris Translat Res Ctr Organ Transplantat, Paris, France
[3] Cedars Sinai Med Ctr, Dept Cardiol, Smidt Heart Inst, Los Angeles, CA 90048 USA
来源
关键词
heart transplantation; mechanical circulatory support; prognosis; survival; risk score; HEART-TRANSPLANT; SURVIVAL; DONOR; MORTALITY; RECIPIENT; ALLOCATION; INDEX; STRATIFICATION; PREDICTION; REGISTRY;
D O I
10.1016/j.healun.2021.06.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The clinical use of post-transplant risk scores is limited by their poor statistical performance. We hypothesized that developing specific prognostic models for each type of circulatory support at transplant may improve risk stratification. METHODS: We analyzed the UNOS database including contemporary, first, non-combined heart transplantations (2013-2018). The endpoint was death or retransplantation during the first year post-transplant. Three different circulatory support statuses at transplant were considered: no support, durable mechanical support and temporary support (inotropes, temporary mechanical support). We generated 1,000 bootstrap samples that we randomly split into derivation and test sets. In each sample, we derived an overall model and 3 specific models (1 for each type of circulatory support) using Cox regressions, and compared, in the test set, their statistical performance for each type of circulatory support. RESULTS: A total of 13,729 patients were included; 1,220 patients (8.9%) met the composite endpoint. Circulatory support status at transplant was associated with important differences in baseline characteristics and distinct prognosis (p = 0.01), interacted significantly with important predictive variables included in the overall model, and had a major impact on post-transplant predictive models (type of variables included and their corresponding hazard ratios). However, specific models suffered from poor discriminative performance and significantly improved risk stratification (discrimination, reclassification indices, calibration) compared to overall models in a very limited proportion of bootstrap samples (<15%). These results were consistent across several sensitivity analyzes. CONCLUSION: Circulatory support status at transplant reflected different disease states that influenced predictive models. However, developing specific models for each circulatory support status did not significantly improve risk stratification. (C) 2021 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:1235 / 1246
页数:12
相关论文
共 50 条
  • [21] Do Heart-Kidney Transplant Candidates on Mechanical Circulatory Support Have Acceptable Outcomes Post-Transplant?
    Patel, J.
    Kittleson, M.
    Skorka, R.
    Ramzy, D.
    Megna, D.
    Emerson, D.
    Cole, R.
    Knabe, K.
    Patel, N.
    Singer-Englar, T.
    Czer, L.
    Kobashigawa, J. A.
    Moriguchi, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S263 - S264
  • [22] Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era
    Salas, Maria Queralt
    Rodriguez-Lobato, Luis Gerardo
    Charry, Paola
    Suarez-Lledo, Maria
    Pedraza, Alexandra
    Teresa Solano, Maria
    Arcarons, Jordi
    Cid, Joan
    Lozano, Miquel
    Rosinol, Laura
    Esteve, Jordi
    Carreras, Enric
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S3 - S12
  • [23] Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era
    Salas, Maria Queralt
    Rodriguez-Lobato, Luis Gerardo
    Charry, Paola
    Suarez-Lledo, Maria
    Pedraza, Alexandra
    Solano, Maria Teresa
    Arcarons, Jordi
    Cid, Joan
    Lozano, Miquel
    Rosinol, Laura
    Esteve, Jordi
    Carreras, Enric
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S3 - S12
  • [24] Post-Transplant Lymphoproliferative Disorder: Risk Analysis for Pancreas Transplant Patients.
    Minja, E.
    Dunn, T.
    Matas, A.
    Pruett, T.
    Kandaswamy, R.
    Finger, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 686 - 686
  • [25] Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort
    Katz, B. Z.
    Pahl, E.
    Crawford, S. E.
    Kostyk, M. C.
    Rodgers, S.
    Seshadri, R.
    Proytcheva, M.
    Pophal, S.
    PEDIATRIC TRANSPLANTATION, 2007, 11 (01) : 58 - 65
  • [26] High mortality of UNOS status 1 heart transplant candidates - Call for consideration of mechanical circulatory support
    Lietz, Katherine
    Miller, Leslie W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 78A - 78A
  • [27] Development of Limited Sampling Strategies for Tacrolimus According to the Post-Transplant Period
    Aouam, K.
    Chadly, Z.
    Chaabane, A.
    Ben Fredj, N.
    Hammouda, M.
    El May, M.
    Boughattas, N. A.
    Skhiri, Habib
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 705 - 705
  • [28] Timing of Ventricular Assist Device Insertion on Post-Transplant Outcomes: An Analysis of the UNOS Database
    Conway, J.
    Lake, M.
    Morales, D.
    Buchholz, H.
    Lorts, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S78 - S78
  • [29] Patients Bridged to Transplant with Durable LVAD Support Have a Higher Risk of Post-Transplant De Novo Donor Specific Antibodies
    Cole, R. T.
    Minto, J.
    Bogar, L.
    Miller, H.
    Morris, A.
    Gupta, D.
    Smith, A.
    Vega, J.
    Laskar, S.
    Bhatt, K.
    Shah, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S150 - S151
  • [30] Validation of transplant risk assessment scores within normothermic machine perfusion treated liver transplant cohort
    Wehrle, Chase
    Zhang, Mingyi
    Ali, Khaled
    Panconesi, Rebecca
    Nadeem, Muhammad
    Karakaya, Omer
    Sun, Keyue
    Jiao, Chunbao
    Shanmugarajah, Kumaran
    Wakam, Glenn
    Shoucair, Sami
    Wu, Wei
    Isaacson, Dylan
    Kim, Jaekeun
    Kwon, David
    Aucejo, Federico
    Pita, Alejandro
    Khalil, Mazhar
    Fujiki, Masato
    Miller, Charles
    Hashimoto, Koji
    Schlegel, Andrea
    AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (01)